Tirth T. Patel

Hermes Investment Management Ltd. (HIML) is an asset management firm headquartered in London, UK. They are a subsidiary of Federated Hermes Ltd., ultimately held by Federated Hermes, Inc. (NYSE: FHI) in the US. In 1990, the firm was founded as PostTel and subsequently changed their name to PosTel Financial Asset Management Ltd. They became Hermes Investment Management Ltd. in 1995. HIML provides discretionary and non-discretionary investment management services to institutional clients.

Edison Investment Research Ltd. (Edison) is an investment research, investor relations and consulting firm headquartered in London, UK. The firm was founded by Stephen Rogers and Fraser Thorne in 2003. They are a subsidiary of Edison Global Ltd. Edison provides investment research to international investors, advisors and stakeholders.

CFA Society of the UK is an association of investment professionals based in the UK. The British company was founded in an unspecified year.

Edison Group, Inc. provides technology analysis and business consulting services. Its services include advisory, competitive research, end to end modern marketing, and results and sample deliverables. The company was founded by Dan Spiner in 2005 and is headquartered in New York, NY.

Edison Global Ltd. is a leading investor relations business that operates across major capital markets. The private company is based in London, UK and has subsidiaries in the United States, New Zealand, Germany, the United Kingdom, and Australia. The British company specializes in creating optimal valuations for client stocks through their intelligent strategic advice, equity research, investor marketing, and direct engagement.

Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million.